Literature DB >> 11063898

Immunohistochemical detection of estrogen and progesterone receptor in human cornea.

P V Vécsei1, K Kircher, S Kaminski, G Nagel, G Breitenecker, P D Kohlberger.   

Abstract

OBJECTIVE: For treatment of postmenopausal keratoconjunctivitis sicca hormone therapy is favored by some clinicians. The likely morphological basis assessing the hormone receptor status in the human cornea has not been performed. Immunohistochemical staining methods provide the opportunity to evaluate the hormone receptor content within the histologic compartments of the cornea. The aim of our study was to assess and localize immunohistochemical hormone receptor staining in the human cornea.
METHODS: Formalin-fixed and paraffin-embedded specimens of three pre- and three postmenopausal women were assessed for localization of estrogen receptor (ER) and progesterone receptor (PR) expression with established immunohistochemical hormone receptor staining methods.
RESULTS: No nuclear staining reaction was found in the epi- and endothelial layers of the corneas. The stroma of the corneas showed no immunohistochemical staining reaction in all cases. We found cytoplasmatic PR staining of the endothelial layer in two cases.
CONCLUSIONS: We found no morphological basis in the human cornea for the use of topical steroid hormone treatment in postmenopausal keratoconjunctivitis sicca. Hormone receptor expression in the conjunctiva or in the lacrimal gland may have an impact in some patients showing relief of symptoms in postmenopausal dry eye syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063898     DOI: 10.1016/s0378-5122(00)00156-0

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  8 in total

1.  The effect of estrogen and progesterone on porcine corneal biomechanical properties.

Authors:  Eyal Walter; Ran Matlov Kormas; Arie L Marcovich; Yotam Lior; Xiaomeng Sui; Daniel Wagner; Boris Knyazer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-17       Impact factor: 3.117

2.  Evaluation of corneal thickness alterations during menstrual cycle in productive age women.

Authors:  Negar Amiri Ghahfarokhi; Ali Vaseghi; Negin Amiri Ghahfarokhi; Mohammad Ghoreishi; Alireza Peyman; Alireza Dehghani
Journal:  Indian J Ophthalmol       Date:  2015-01       Impact factor: 1.848

3.  Topical Estrogen Therapy for Hyperopia Correction in Vivo.

Authors:  Ari Leshno; Katalin Prokai-Tatrai; Ygal Rotenstreich; Asaf Magid; Ettel Bubis; Shulamit Schwartz; Alon Skaat; Ofira Zloto; Noa Avni-Zauberman; Adiel Barak
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-06-03       Impact factor: 4.799

4.  Corneal characteristics in Down syndrome patients with normal and keratoconic cornea.

Authors:  Hassan Hashemi; Soheila Asgari
Journal:  Front Med (Lausanne)       Date:  2022-09-16

5.  Corneal topographic changes in premenopausal and postmenopausal women.

Authors:  Erdinc Aydin; Helin Deniz Demir; Fazli Demirturk; Ahmet Cantug Caliskan; Hakan Aytan; Unal Erkorkmaz
Journal:  BMC Ophthalmol       Date:  2007-05-14       Impact factor: 2.209

6.  The Role of Estriol and Estrone in Keratoconic Stromal Sex Hormone Receptors.

Authors:  Paulina Escandon; Sarah E Nicholas; Rebecca L Cunningham; David A Murphy; Kamran M Riaz; Dimitrios Karamichos
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

Review 7.  Sex Hormones, Growth Hormone, and the Cornea.

Authors:  Tina B McKay; Shrestha Priyadarsini; Dimitrios Karamichos
Journal:  Cells       Date:  2022-01-11       Impact factor: 6.600

Review 8.  Sex Hormones and Their Effects on Ocular Disorders and Pathophysiology: Current Aspects and Our Experience.

Authors:  Raffaele Nuzzi; Paolo Caselgrandi
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.